"The headline-grabbing iPhone 4 from Apple has generated a lot of buzz, including a wave of interest in Omnivision Technologies (OVTI)," says growth stock specialist Mike Cintolo.

The editor of Cabot Top Ten Report explains, "The company is a designer and manufacturer of tiny cameras that turn smart phones into image recorders. As iPhone sales soar, so does OmniVision, which has been confirmed as the maker of the phone's five-megapixel sensor.

In the wake of the incredible volatility of recent days, we turn to several leading financial newsletter advisors, asking "Where's the market going from here?"

Here's an updated assessment -- as well as some select investment ideas -- from Elliott Gue, Richard Moroney, Nicholas Vardy, Keith Fitz-Gerald and Mike Cintolo.

We begin with Elliott Gue, editor of The Energy Strategist, who asserts, "Don't panic. Selling into a panic-driven market is one of the worst and most costly mistakes you can make as an investor. I do not believe the fundamentals justify the downside in my recommended stocks, nor do I see this ballooning into an outright crash or collapse.

"Why are we seeing strength in select retailers such as AnnTaylor (ANN), Philip-Van Heusen (PVH) and Talbots (TLB)? asks Mike Cintolo.

The editor of Cabot Top Ten Report explains, "The world of retail is a harsh and unforgiving one, especially when the U.S. and global economies are still technically in a recession. But investors are always looking ahead, and right now they like what they see.

"If you use a mobile phone with a camera, thank Tessera (NASDAQ: TSRA)," says Mike Cintolo in the Cabot Top Ten Report. "When it comes to miniaturization, Tessera is the go-to company."

"Tessera is one of the companies that drove the price of camera components down by miniaturizing them and combining them on a single chip.

"You'll find its technology in MP3 players, video games, wireless phones, computers and numerous other products where companies are forever working to design products smaller and manufacture them more cheaply.

"Illumina (NASDAQ: ILMN) makes the Genome Analyzer, which is the workhorse of the genetic medicine revolution," says growth expert Mike Cintolo in The Cabot Top Ten Report.

"The Illumina Genome Analyzer is used by genomic research centers, academic institutions, agriculture and livestock companies, pharmaceutical companies, clinical research organizations and biotechnology companies all over the world.

"In the fourth quarter of 2008, for example, the company launched the In? nium HD HumanCytoSNP-12 BeadChip, a 12 sample BeadChip priced as low as $125 per sample that enables researchers to analyze nearly 300,000 genetic markers per sample.

"Our favorite current investment idea is Netflix (NASDAQ: NFLX)," says Michael Cintolo, editor of The Cabot Top Ten Report, which each week reviews ten issues that have been showing strong price momentum.

"Netflix bolted higher on a great earnings report last week, and impressively, followed through to the upside for a few days. Bad economic times seem to mean good news for Netflix, as an evening at home with a few DVDs is way easier on the budget than even a bargain matinee at the Cineplex.

"That's the message of Netflix' boffo quarterly results that came out on January 26. Earnings walloped analysts' estimates and more than twice the predicted number of new subscribers signed up.